Mechanism of Action: P2Y12 Receptor Antagonists
✉ Email this page to a colleague
Drugs with Mechanism of Action: P2Y12 Receptor Antagonists
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amneal | TICAGRELOR | ticagrelor | TABLET;ORAL | 208531-001 | Jan 23, 2019 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Unichem | PRASUGREL HYDROCHLORIDE | prasugrel hydrochloride | TABLET;ORAL | 213315-001 | Aug 28, 2023 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Unichem | PRASUGREL HYDROCHLORIDE | prasugrel hydrochloride | TABLET;ORAL | 213315-002 | Aug 28, 2023 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Mylan | PRASUGREL | prasugrel hydrochloride | TABLET;ORAL | 205927-001 | Jul 12, 2017 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Aurobindo Pharma | PRASUGREL | prasugrel hydrochloride | TABLET;ORAL | 205888-001 | Oct 16, 2017 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Mylan | PRASUGREL | prasugrel hydrochloride | TABLET;ORAL | 205927-002 | Jul 12, 2017 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Aurobindo Pharma | PRASUGREL | prasugrel hydrochloride | TABLET;ORAL | 205888-002 | Oct 16, 2017 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
